The role of bronchoplasty in the treatment of lung cancer

Ann Chir Gynaecol. 1997;86(1):31-7.

Abstract

Over a half of the patients with lung cancer have inoperable disease on diagnosis. Limited respiratory reserve due to chronic pulmonary disease can preclude patients from pneumonectomy. A bronchoplastic resection can be used to circumvent pneumonectomy in selected cases. Its applicability in lung cancer was investigated by following up a total of 28 patients who underwent this procedure for lung cancer between 1973 and 1993 in our institution. This was only approximately 1.4% of all our lung cancer operations. The actuarial five-year survival probability was 40%, and the complication rate was 16%. These values are comparable to those reported in the literature and to those of pneumonectomy. It appears that the ideal cases with a proximal tumour but limited disease are rare.

MeSH terms

  • Actuarial Analysis
  • Adult
  • Aged
  • Anastomosis, Surgical / methods
  • Bronchi / pathology
  • Bronchi / surgery*
  • Carcinoma, Non-Small-Cell Lung / mortality
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Carcinoma, Non-Small-Cell Lung / surgery*
  • Female
  • Humans
  • Lung Neoplasms / mortality
  • Lung Neoplasms / pathology
  • Lung Neoplasms / surgery*
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Palliative Care
  • Pneumonectomy / methods*
  • Postoperative Complications / etiology
  • Postoperative Complications / mortality
  • Prognosis
  • Survival Rate